NasdaqGS:ICLRLife Sciences
Is ICON (ICLR) Quietly Redefining Its Oncology Moat With the Brian Moran Institute Expansion?
In January 2026, ICON plc expanded its oncology research capabilities by opening the Brian Moran Cancer Institute at Duly Health and Care in Illinois, adding a comprehensive team of medical, radiation, and surgical oncology specialists to its Accellacare Site Network.
This move deepens Accellacare’s ability to support oncology clinical trials and tackle one of the sector’s toughest issues: recruiting enough suitable patients for increasingly complex cancer studies.
We will now examine how...